AMOpportunities recently announced an additional $2 million to its Series A2 from new investors Laerdal Million Lives Fund and LAGO Innovation Fund, as well as current investors PACE Healthcare Capital, OCA Ventures, and HealthX Ventures. This funding round is now fully subscribed and will close imminently. And this brings the total funding to nearly $11 million.
The Laerdal Million Lives Fund launched in 2020 to invest in enabling technologies and platforms capable of saving lives by improving healthcare quality and education of healthcare workers. And the Million Lives Fund is backed by Laerdal Medical, the world-leading provider of training, educational, and therapy products for healthcare providers, voluntary organizations, educational institutions, hospitals, and the military worldwide. They are investing $1 million and joining the Board in an observer capacity.
LAGO Innovation Fund, AMO’s current lender, is investing in equity and committing to invest $50K. And AMOpportunities will use the additional funding to continue to expand its network of U.S. hospitals and clinical partners as well as global medical schools.
This funding round comes on the heels of other exciting announcements from the company, including welcoming Dr. Kevin Klauer as senior advisor for strategic partnerships; appointing Jon David Willingham to its Board of Directors; and the celebration of its 10th anniversary.
KEY QUOTES:
“We are thrilled that Laerdal Million Lives Fund and LAGO Innovation Fund are joining our Series A2 financing to complete our $2 million round. Both organizations have invested in incredible companies, and we’re proud to join their growing list of investments.”
— Kyle Swinsky, CEO, AMOpportunities
“AMOpportunities aligns with our mission of supporting disruptive and innovative education and learning platforms across the healthcare space. AMO is playing a meaningful role in educating the next generation of healthcare professionals—giving these learners unique access to clinical experiences and rotations that are essential to building a more robust network of clinical workers. At the Million Lives Fund, our goal of improving healthcare quality, increasing skills and proficiencies of healthcare workers globally and reducing preventable medical errors is aligned with the ROI and value propositions AMO delivers to their customers. We’re excited to invest in the company, join their Board, and be a part of their future growth strategy.”
— Jeff Trost, Managing Partner of the Million Lives Fund
“In the past year, AMO has made tremendous strides in our work towards bridging the healthcare gap. This funding demonstrates the confidence our current investors, and now new additions, have in AMO as we continue to address the healthcare provider shortage.”
— Ben Bradley, COO, AMO
